Kirsi Toivanen
Overview
Explore the profile of Kirsi Toivanen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
1
Citations
0
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pharmacokinetic profile and anticancer efficacy of anagrelide administered subcutaneously in rodents
Toivanen K, Sutter L, Wozniak A, Wyns K, Merikoski N, Salmikangas S, et al.
Drug Deliv
. 2025 Feb;
32(1):2463433.
PMID: 39930717
Anagrelide (ANA) is a phosphodiesterase 3A (PDE3A) inhibitor, commonly prescribed for essential thrombocythemia. It also functions as a molecular glue, inducing complex formation between PDE3A and Schlafen 12. This association...
2.
Toivanen K, Kilpinen S, Ojala K, Merikoski N, Salmikangas S, Sampo M, et al.
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001568
Liposarcomas (LPSs) are a heterogeneous group of malignancies that arise from adipose tissue. Although LPSs are among the most common soft-tissue sarcoma subtypes, precision medicine treatments are not currently available....